Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.

Faster global financial news!

BridgeBio Pharma, Inc.

BBIO NASDAQHealthcare ★★★★★
Market Cap $13.17B
Latest Earnings Below forecast↓
Date
Aug 10, 2026
ET
EPS Est.
-0.58
EPS Actual
-0.78
Revenue Est.
$220.9M
Revenue Actual
$243.7M
Next Earnings Report
Date
Oct 28, 2026 · Wed
ET Oct 28, 2026 · Wed
Time
10/28 20:00-10/29 00:00
After-market(ET)
Fiscal Period
FY2026 Q3
EPS Est.
-0.67
Revenue Est.
$269M
Company Overview
BridgeBio Pharma, Inc. (ticker BBIO) is listed on NASDAQ with a market cap of about $13.17B. Its next earnings report (FY2026 Q3) is expected on Oct 28, 2026 (ET), After-market, with consensus EPS of -0.67. In the last 15 reported quarters, EPS beat consensus estimates 4 times.
Actual EPS TrendRecently15Term · Feb 23, 2023 → Aug 10, 2026
Feb 23, 2023Range: -1.31 ~ -0.20Aug 10, 2026
Earnings History
Date Fiscal Period EPS Est. EPS Actual Revenue Est. Revenue Actual
Aug 10, 2026 -- -0.58 Below forecast↓-0.78 $220.9M $243.7M
May 7, 2026 -- -0.68 Below forecast↓-0.84 $178.1M $194.5M
Feb 24, 2026 -- -0.71 Below forecast↓-1.00 $146.8M $154.2M
Oct 29, 2025 -- -0.88 Below forecast↓-0.95 $148.2M $120.7M
Aug 5, 2025 -- -0.83 Below forecast↓-0.95 $108.1M $110.6M
Apr 29, 2025 -- -1.00 Above forecast↑-0.88 $68.4M $116.6M
Feb 20, 2025 -- -1.09 Below forecast↓-1.31 $4M $5.9M
Nov 12, 2024 -- -1.03 Above forecast↑-0.86 $67.3M $2.7M
Aug 1, 2024 -- -1.09 Above forecast↑-0.39 $4M $2.2M
May 2, 2024 -- -0.71 Above forecast↑-0.20 $7.3M $211.1M
Feb 22, 2024 -- -0.95 Below forecast↓-0.96 $6.2M $1.7M
Nov 2, 2023 -- -0.86 Below forecast↓-1.08 $4.3M $4.1M
Aug 3, 2023 -- -0.86 Below forecast↓-0.98 $3M $1.6M
May 4, 2023 -- -0.84 Below forecast↓-0.92 $3.4M $1.8M
Feb 23, 2023 -- -0.86 Below forecast↓-0.87 $4.5M $1.9M
Original Filings (SEC)
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website. For some foreign private issuers (ADRs), the earnings filing is typically submitted to the SEC several days after the results are announced; it will appear here automatically once filed.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
Current Location: Home > Economic Calendar > Earnings Calendar > BBIO